Strattera en es it fr

Strattera Brand names, Strattera Analogs

Strattera Brand Names Mixture

  • No information avaliable

Strattera Chemical_Formula


Strattera RX_link

Strattera fda sheet

Strattera FDA

Strattera msds (material safety sheet)

Strattera Synthesis Reference

No information avaliable

Strattera Molecular Weight

255.355 g/mol

Strattera Melting Point

No information avaliable

Strattera H2O Solubility

No information avaliable

Strattera State


Strattera LogP


Strattera Dosage Forms


Strattera Indication

For the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).

Strattera Pharmacology

Atomoxetine is an amphetamine used to treat ADD/ADHD in children and adults. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimulant activity. It increases motor activity and mental alertness, and reduces drowsiness and a sense of fatigue, decreasing motor restlessness and improves one's ability to focus. Peripheral actions include elevation of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action. There is neither specific evidence which clearly establishes the mechanism whereby amphetamine produces mental and behavioral effects in children, nor conclusive evidence regarding how these effects relate to the condition of the central nervous system. Atomoxetine activates the brain stem arousal system and cortex to produce its stimulant effect.

Strattera Absorption

No information avaliable

Strattera side effects and Toxicity

No information avaliable

Strattera Patient Information

Strattera Organisms Affected

Humans and other mammals